The Life Sciences Imperative
Life sciences is where innovation directly saves lives. As an IS-8 priority sector, the UK's pharmaceutical and biotech industries are critical to both health outcomes and economic growth.
But drug development is notoriously slow and expensive. The average new drug takes over a decade and billions of pounds to bring to market. Any acceleration in this process has enormous human and economic value.
How Blocks Accelerates Life Sciences
Research Pipeline Management
Blocks lets research organisations configure how compounds flow through development:
- Visual trial phase builder - Design clinical workflows without code
- Automated regulatory documentation - Generate FDA/EMA submissions
- Real-time trial monitoring - Track patient recruitment and outcomes
- Complete audit trails - GxP-compliant by design
AI-Powered Discovery
Our AI tools help researchers:
- Analyse complex biological datasets
- Identify promising compound candidates
- Predict trial outcomes based on historical data
- Automate literature review and analysis
Lab Operations
Blocks streamlines day-to-day research:
- Equipment scheduling and maintenance
- Sample tracking and chain of custody
- Protocol management and reproducibility
- Integration with LIMS and lab equipment
Results for Life Sciences Companies
A pharmaceutical company using Blocks achieved:
- 40% improvement in trial enrollment
- 30% reduction in regulatory submission time
- Significant acceleration in early-stage research
Supporting UK Life Sciences
The UK Government's investment in life sciences recognises the sector's importance. Blocks helps by:
- Accelerating research through intelligent automation
- Reducing compliance burden with built-in GxP support
- Enabling collaboration across research sites
- Protecting IP with secure data handling